MedPath

Investigating the effect of omega-3 supplementation on inflammatory indices of dialysis patients

Phase 3
Conditions
Patients with chronic kidney failure undergoing hemodialysis.
Chronic kidney disease (CKD)
Registration Number
IRCT20151226025699N6
Lead Sponsor
Rasht University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Written consent
Age over 20 years

Exclusion Criteria

No tendency to participate in the study
Having incomplete medical records
Consumption of omega-3 fatty acids supplementation during the last 3-month before the study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath